Fluvastatin on acute coronary syndrome serum high-sensitivity C-reactive protein and the impact of MMP-9.docVIP

Fluvastatin on acute coronary syndrome serum high-sensitivity C-reactive protein and the impact of MMP-9.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Fluvastatin on acute coronary syndrome serum high-sensitivity C-reactive protein and the impact of MMP-9

 PAGE \* MERGEFORMAT 9 Fluvastatin on acute coronary syndrome serum high-sensitivity C-reactive protein and the impact of MMP-9 [Abstract] Objective of fluvastatin on acute coronary syndrome (ACS) serum high-sensitivity C-reactive protein (hs-CRP) and matrix metalloproteinase -9 (MMP-9) levels. Methods ACS 68 patients were randomly divided into fluvastatin treatment group, 34 patients in the control group, 34 patients compared the levels of serum hs-CRP, MMP-9 levels. Results After 4 weeks, fluvastatin serum levels of hs-CRP, MMP-9 levels were significantly lower in the control group (P lt;0.05), blood lipid changes between the two groups no significant difference (Pgt; 0.05). Conclusion Fluvastatin reduces the ACS patients hs-CRP, MMP-9 levels, inhibiting the inflammatory response, and stability of atherosclerotic plaques. [Keywords:] Acute coronary syndrome; matrix metalloproteinase; C reactive protein; fluvastatin Abstract Objective To discuss the affection of fluvastatin on the serum level of high sensitive C-reactive protein (hs-CRP) and of matrix metalloprotease-9 (MMP-9) in patients with acute coronary syndrome (ACS). Methods 68 cases with ACS were randomly divided into 2 groups: fluvastatin group and control group, 34 cases in each; the changes of hs-CRP and MMP-9 of the patients in the 2 groups were compared.Result 4 weeks after treatment, the serum level of hs- CRP and of MMP-9 of the patients in fluvastatin group were much lower than that of the patients in control group (P lt;0.05) while the comparison of the blood-lipid changes between the 2 groups was of no statistical difference (P lt;0.05 ). Conclusions Fluvastatin can decrease the serum level of hs-CRP and of MMP-9 in patients with ACS, inhibit the inflammatory responses and stabilize atherosclerotic plaque. KEYWORDS acute coronary syndrome matrix metalloprotease-9 C-reactive protein fluvastatin Local or systemic inflammation in coronary artery atherosclerosis and play an importa

文档评论(0)

jiupshaieuk12 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:6212135231000003

1亿VIP精品文档

相关文档